Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Hasegawa, Daisuke  [Clear All Filters]
Journal Article
Raghuram N, Nakashima K, Rahman SAb, Antoniou E, Skajaa T, Merli P, Verma A, Rabin KR, Aftandilian C, Kotecha RSury, et al. Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome. Blood Adv. 2023.
Yamamoto S, Kato M, Watanabe K, Ishimaru S, Hasegawa D, Noguchi M, Hama A, Sato M, Koike T, Iwasaki F, et al. Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome. Bone Marrow Transplant. 2021.
Tomizawa D, Tsujimoto S-I, Tanaka S, Matsubayashi J, Aoki T, Iwamoto S, Hasegawa D, Nagai K, Nakashima K, Kawaguchi K, et al. A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemothe. Jpn J Clin Oncol. 2022.
Imai C, Sato A, Hiwatari M, Shimomura Y, Hori T, Suenobu S, Imamura T, Hara J, Hasegawa D, Takahashi H, et al. Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia. Int J Hematol. 2023.
Ishimaru S, Okamoto Y, Imai C, Sakaguchi H, Taki T, Hasegawa D, Cho Y, Kakuda H, Sano H, Manabe A, et al. Nationwide Survey of Pediatric Hypodiploid Acute Lymphoblastic Leukemia in Japan. Pediatr Int. 2019.